These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 27867890)

  • 21. Insight into the potential of bone turnover biomarkers: integration in the management of osteoporosis and chronic kidney disease-associated osteoporosis.
    Brouwers P; Bouquegneau A; Cavalier E
    Curr Opin Endocrinol Diabetes Obes; 2024 Aug; 31(4):149-156. PubMed ID: 38804196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of bone turnover markers in the management of common metabolic bone diseases in adults.
    Glendenning P; Chubb SAP; Vasikaran S
    Clin Chim Acta; 2018 Jun; 481():161-170. PubMed ID: 29544749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone turnover markers in the management of postmenopausal osteoporosis.
    Brown JP; Albert C; Nassar BA; Adachi JD; Cole D; Davison KS; Dooley KC; Don-Wauchope A; Douville P; Hanley DA; Jamal SA; Josse R; Kaiser S; Krahn J; Krause R; Kremer R; Lepage R; Letendre E; Morin S; Ooi DS; Papaioaonnou A; Ste-Marie LG
    Clin Biochem; 2009 Jul; 42(10-11):929-42. PubMed ID: 19362543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis.
    Delmas PD; Munoz F; Black DM; Cosman F; Boonen S; Watts NB; Kendler D; Eriksen EF; Mesenbrink PG; Eastell R;
    J Bone Miner Res; 2009 Sep; 24(9):1544-51. PubMed ID: 19338427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consensus Statement on the Use of Bone Turnover Markers for Short-Term Monitoring of Osteoporosis Treatment in the Asia-Pacific Region.
    Wu CH; Chang YF; Chen CH; Lewiecki EM; Wüster C; Reid I; Tsai KS; Matsumoto T; Mercado-Asis LB; Chan DC; Hwang JS; Cheung CL; Saag K; Lee JK; Tu ST; Xia W; Yu W; Chung YS; Ebeling P; Mithal A; Ferrari SL; Cooper C; Lin GT; Yang RS
    J Clin Densitom; 2021; 24(1):3-13. PubMed ID: 31010789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Changes of CTX, DPD, Osteocalcin, and Bone Mineral Density During the Postmenopausal Period.
    Park SG; Jeong SU; Lee JH; Ryu SH; Jeong HJ; Sim YJ; Kim DK; Kim GC
    Ann Rehabil Med; 2018 Jun; 42(3):441-448. PubMed ID: 29961742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The challenge of long-term adherence: The role of bone turnover markers in monitoring bisphosphonate treatment of osteoporosis.
    Fontalis A; Eastell R
    Bone; 2020 Jul; 136():115336. PubMed ID: 32234415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Use of Bone-Turnover Markers in Asia-Pacific Populations.
    Vasikaran S; Thambiah SC; Tan RZ; Loh TP;
    Ann Lab Med; 2024 Mar; 44(2):126-134. PubMed ID: 37869778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone Turnover Markers: Use in Fracture Prediction.
    Vilaca T; Gossiel F; Eastell R
    J Clin Densitom; 2017; 20(3):346-352. PubMed ID: 28716498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical points in strategies for the diagnosis and treatment of osteoporosis.
    Lorenc RS; Misiorowski W; Karczmarewicz E
    Endokrynol Pol; 2009; 60(2):124-33. PubMed ID: 19396756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary Bone Turnover Markers as Target Indicators for Monitoring Bisphosphonate Drug Treatment in the Management of Osteoporosis.
    Kwon S; Wang AH; Sadowski CA; Yuksel N; Doschak MR
    Curr Drug Targets; 2018; 19(5):451-459. PubMed ID: 28676000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical utility of bone marker measurements in osteoporosis.
    Wheater G; Elshahaly M; Tuck SP; Datta HK; van Laar JM
    J Transl Med; 2013 Aug; 11():201. PubMed ID: 23984630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Application of Bone Turnover Markers in Osteoporosis in Korea.
    Park SY; Ahn SH; Yoo JI; Chung YJ; Jeon YK; Yoon BH; Kim HY; Lee SH; Lee J; Hong S
    J Bone Metab; 2019 Feb; 26(1):19-24. PubMed ID: 30899720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postmenopausal osteoporosis treatment with antiresorptives: effects of discontinuation or long-term continuation on bone turnover and fracture risk--a perspective.
    Boonen S; Ferrari S; Miller PD; Eriksen EF; Sambrook PN; Compston J; Reid IR; Vanderschueren D; Cosman F
    J Bone Miner Res; 2012 May; 27(5):963-74. PubMed ID: 22467094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical Considerations for the Clinical Application of Bone Turnover Markers in Osteoporosis.
    Vasikaran SD; Miura M; Pikner R; Bhattoa HP; Cavalier E;
    Calcif Tissue Int; 2023 Feb; 112(2):148-157. PubMed ID: 34846540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of bone turnover markers in screening low bone mineral density and their relationship with fracture risk in the postmenopausal period.
    Mobasseri M; Tarverdizadeh N; Mirghafourvand M; Salehi-Pourmehr H; Ostadrahimi A; Farshbaf-Khalili A
    J Res Med Sci; 2023; 28():54. PubMed ID: 37496649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between bone turnover and density with teriparatide, denosumab or both in women in the DATA study.
    Tsai JN; Burnett-Bowie SM; Lee H; Leder BZ
    Bone; 2017 Feb; 95():20-25. PubMed ID: 27840301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are bone turnover markers associated with volumetric bone density, size, and strength in older men and women? The AGES-Reykjavik study.
    Marques EA; Gudnason V; Sigurdsson G; Lang T; Johannesdottir F; Siggeirsdottir K; Launer L; Eiriksdottir G; Harris TB
    Osteoporos Int; 2016 May; 27(5):1765-76. PubMed ID: 26630978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.